Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
(NASDAQ: CRVS) Delayed: 12.63 +0.07 (0.56%)
Previous Close $12.56    52 Week High $17.77 
Open $12.10    52 Week Low $9.63 
Day High $13.07    P/E N/A 
Day Low $12.09    EPS $0.00 
Volume 920,048